While the mechanism of enhanced tumor cell killing is unknown, FcγR-bearing NSG myeloid cells can bind human IgG1 and IgG4 and may have some role in tumor cell clearance in the presence of anti-PD-L1 IgG1 or IgG4 isotypes [29]. The gene discussed is CD274; the disease is neoplasm.